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Abstract
Background: Puncture-induced radial artery spasm (RAS) may extend the duration of coronary an-
giography (CAG) or cause transradial access failure. Flow-mediated dilatation (FMD), a widely-used 
noninvasive approach for assessing endothelial function, was reported to remove the entrapped radial 
sheath after percutaneous coronary intervention. Herein, the efficacy and safety of FMD in treating 
puncture-induced RAS before transradial CAG was investigated.
Methods: Ninety patients with puncture-induced RAS were randomized in a 1:1:1 ratio into three 
groups: FMD group was immediately treated with blockage of brachial artery blood for 5 min using 
a sphygmomanometric cuff and then rapid relief; nitroglycerin (NTG) group was administered with 
0.5 mg sublingual NTG instantly; and the no-therapy group was treated with a wait-and-watch strategy. 
The time of radial pulse recovery, and regional and systemic complications were recorded.
Results: The rate of radial pulse recovery within 30 min in FMD group was significantly higher 
than that in no-therapy group (97% vs. 73%, p = 0.026). The median time to return of radial pulse in 
FMD group and NTG group was significantly shorter than that in no-therapy group (7 [6.5–9] min vs.  
15 [12–18] min, 8 [7–9] min vs. 15 [12–18] min, respectively; both p < 0.001). Headache and decreased 
blood pressure were more prevalent in NTG group than those in FMD and no-therapy groups. 
Conclusions: FMD is a feasible, noninvasive and nonpharmacological approach to relieve RAS and 
facilitate radial artery cannulation after an initial failed attempt. (Cardiol J 2018; 25, 1: 1–6)
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Introduction
Radial artery access has been an increasingly 
widespread approach for coronary angiography 
(CAG) or percutaneous coronary intervention 
(PCI) [1] since Campeau [2] reported the first case 
in 1989 and its improvement was described by 
Kiemeneij and Laarman in 1993 [3]. Compared with 
transfemoral access, transradial access decreases 
vascular-related and bleeding complications [4, 5], 
reduces in-hospital stay and hospitalization costs 
[6] while improving patient comfort [7] and pre-
ferred by patients. Moreover, the transradial 
approach significantly reduces all-cause mortality 
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and major adverse cardiovascular events for pa-
tients with ST-elevated myocardial infarction 
undergoing PCI [8]. However, radial artery spasm 
(RAS) which happens during puncture, CAG/PCI or 
removal of the sheath after the procedure with an 
incidence of 3–10%, is an important reason for tran-
sradial approach failure and access site switch [9]. 
Some investigators have reported that nitroglyc-
erin (NTG) given sublingually was effective in 
facilitating radial artery cannulation, although this 
approach may have a high risk of systemic side 
effects [10, 11].
Endothelial function is often noninvasively 
measured by flow-mediated dilatation (FMD) [12], 
which demonstrates shear stress-induced response 
of endothelium [13] and was first discovered by 
Schretzenmayr et al. [14]. Nitric oxide, as the 
endothelial-derived vasoactive mediator, plays 
a predominant role in FMD [15, 16]. However, 
FMD is rarely reported as a treatment despite the 
application for evaluation of the risk of coronary 
[17] and peripheral artery disease [18]. Two cases 
demonstrated that FMD was effective in remov-
ing entrapped radial sheath rapidly and success-
fully after the failure of administration of NTG, 
verapamil, and sedative therapy [19]. This study 
aimed at measuring the efficacy and safety of FMD 
as a nonpharmacological method for relieving RAS 
induced by puncture.
Methods
Patient population
This was a prospective, randomized, single-
center, open-label, pilot study, consistent with the 
principles of the Declaration of Helsinki and local 
regulations, approved by the local Ethics Commit-
tee. Written informed consent was obtained from 
each patient before screening. Patients over 18 
years old, scheduled to receive elective CAG or 
PCI via radial artery access and suffered from RAS 
during puncture in the First Affiliated Hospital of 
Nanjing Medical University were eligible for this 
study. RAS was defined as a spasm that resulted 
in weakness or loss of radial artery pulse, hardly 
meeting the demand for re-puncture. Diagnoses 
were made by one experienced operator accord-
ing to palpation (Dr. L. or Dr. Y., who each had 
performed more than 300 cases of successful radial 
artery puncture per year). Before the procedure, 
patients with an abnormal Allen test, known con-
traindications to NTG (hypertrophic obstructive 
cardiomyopathy, severe aortic valve stenosis, 
heart rate < 50 bpm, systolic blood pressure [SBP] 
< 100 mm Hg), and requiring emergency PCI were 
excluded. 
Procedure
Patients were randomly assigned in a ratio of 
1:1:1 to be treated by FMD, NTG or a wait-and-
watch strategy (no-therapy) (Fig. 1). Patients in 
FMD group were immediately treated with block-
ing blood flow of the brachial artery for 5 min by 
a sphygmomanometric cuff wrapped around the 
upper arm with puncture, and the cuff was rapidly 
inflated over 50 mm Hg above SBP, releasing the 
air rapidly for fast recovery of blood flow, as rec-
ommended by the International Brachial Artery 
Reactivity Task Force [20]. Patients in NTG group 
were treated with sublingual administration of 
a single dose of NTG (0.5 mg) as soon as RAS was 
diagnosed. Patients in no-therapy group received 
no special treatment except waiting and watching 
for spontaneous recovery of the radial artery pulse. 
The pulse of the punctured radial artery was evalu-
ated persistently by the same experienced operator 
starting from the diagnosis of RAS, and the pulse 
of adjacent ulnar artery was measured at the same 
time. Evaluation of radial pulse was suspended 
during the inflation of the cuff and restarted after 
loosening the cuff. Recovery of the radial artery 
Figure 1. Study flow chart; CAG — coronary angiogra-
phy; HR — heart rate; FMD — flow mediated dilation; 
NTG — nitroglycerin; PCI — percutaneous coronary in-
tervention; RAS — radial artery spasm; SBP — systolic 
blood pressure.
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pulse was defined as the event that similar pulses 
were obtained from the radial and ulnar arteries. 
The duration of pulse recovery was calculated from 
the diagnosis of RAS to radial artery pulse recov-
ery, including the time of NTG administration and 
compression by cuff. Femoral or contralateral radial 
artery access for CAG was used if no recovery of 
the radial artery pulse was achieved after 30 min 
of observation. Success of pulse recovery and the 
time of recovery were recorded before trying to 
cannulate the radial artery again. Blood pressure, 
heart rate, headache, and local adverse reaction 
of the upper limb with puncture, decreased blood 
pressure (defined as SBP decreasing by over 10% 
during the procedure) and bradycardia (defined as 
heart rate below 50 bpm during the procedure) 
were observed and recorded. Symptomatic hypo-
tension was defined as SBP below 90 mm Hg with 
accompanying symptoms.
Statistical analysis
Analyses were performed using SPSS ver-
sion 19.0 (IBM SPSS, Inc., Chicago, IL, USA) for 
Windows. The Shapiro-Wilk test was used to test 
normality of distribution. Continuous variables with 
normal distribution, continuous variables with non-
normal distribution and categorical variables are 
presented as the mean ± standard deviation, median 
(interquartile range) and number of events (fre-
quency or percentage), respectively. Comparisons 
among the three groups were tested by one-way 
ANOVA for continuous data with a normal distribu-
tion, Kruskal-Wallis H test for continuous data with 
a non-normal distribution or c2 test for categorical 
data. Comparisons between the two groups were 
tested by Kolmogorov-Smirnov test for continuous 
data with non-normal distribution. All hypothesis 
tests were two-sided with 0.05 significance levels.
Results
A total of 2326 patients between October 2015 
and August 2016 were consecutively screened and 
93 (4.0%) of the candidates suffered from RAS 
during puncture. Three patients were excluded 
for various reasons (1 patient with heart rate 
< 50 bpm, 1 patient with SBP < 100 mm Hg, anoth-
er withdrew before enrollment). Ultimately, 90 pa-
tients in all and 30 participants in each group were 
enrolled in this study. The baseline characteristics 
included age, gender, height, weight, body mass 
index, hypertension, diabetes and smoking were 
well matched among the three groups (Table 1). 
Primary endpoints are shown in Figures 2 and 3. 
Twenty-nine out of 30 patients in FMD group 
(97%), 28 out of 30 patients in NTG group (93%) 
and 22 out of 30 patients in no-therapy group (73%) 
had re-establishment of radial pulse and achieved 
radial artery cannulation successfully. The success 
rate of radial pulse recovery in FMD group was 
significantly higher than that in no-therapy group 
(p = 0.026); but the difference between NTG group 
and no-therapy group was not statistically signifi-
cant (p = 0.083). The median recovery time was 
7 (6.5–9) min in FMD group and 8 (7–9) min in NTG 
group; both were remarkably shorter than that in 
no-therapy group (15 [12–18] min; both p < 0.001). 
The incidence of successful recovery of radial ar-
tery pulse and the median recovery time presented 
no significant difference between FMD group and 
NTG group (p = 1.000 and 0.859, respectively). In 
FMD group, 1 patient did not regain the radial pulse 
within 30 min, and the procedure was completed 
via contralateral radial access. In NTG group, 
2 patients with unsuccessful recovery of the radial 
artery pulse were operated on transfemorally. In 
no-therapy group, failure of the radial artery pulse 
Table 1. Baseline clinical characteristics. 
Variable FMD (n = 30) NTG (n = 30) No-therapy (n = 30) P
Age [years] 64.7 ± 10.5 63.1 ± 10.2 63.2 ± 9.9 0.88
Female gender 13 (43%) 14 (47%) 15 (50%) 0.86
Height [cm] 164.5 ± 8.4 162.9 ± 8.1 165.9 ± 8.2 0.37
Weight [kg] 65.9 ± 9.0 65.6 ± 10.5 67.8 ± 12.1 0.69
Body mass index [kg/m2] 24.3 ± 2.3 24.7 ± 3.5 24.5 ± 2.9 0.91
Hypertension 9 (30%) 10 (33%) 14 (47%) 0.37
Diabetes 7 (23%) 8 (27%) 10 (33%) 0.68
Smoking 7 (23%) 8 (27%) 9 (30%) 0.84
Values are presented as mean ± standard deviation or numbers (percentages); FMD — flow mediated dilation; NTG — nitroglycerin
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recovery occurred in 8 patients; contralateral radial 
access was obtained successfully in 4 of them, and 
the procedure was completed transfemorally in 
another 4 patients,
The secondary outcomes are shown in Table 2. 
During the procedure, decreased blood pressure 
was more frequent in NTG group compared with 
those in FMD group and no-therapy group (47% 
vs. 3%, p < 0.001; 47% vs. 3%, p < 0.001, re-
spectively). One patient in NTG group underwent 
symptomatic hypotension and recovered after do-
pamine administration and fluid infusion treatment. 
A total of 40% patients in NTG group complained 
of headache; no other patients in the other groups 
reported headache. One patient in NTG group 
developed bradycardia. No adverse local reactions 
were observed in this study.
Discussion
According to available research, the present 
study was the first pilot study to evaluate the effi-
cacy and safety of FMD as a treatment of puncture-
induced RAS, and the results indicate that FMD is 
an effective noninvasive and nonpharmacological 
method with a higher success rate, reduced recov-
ery time and few systemic complications.  
Although transradial access is in widespread 
use due to  fewer vascular-related and bleeding 
complications compared with transfemoral access, 
this benefit was eliminated by RAS in a small num-
ber of patients. Age > 75 years, a history of coro-
nary artery bypass graft surgery and short stature 
were reported as independent predictors of failure 
of transradial access [21]. The RIVAL trial reported 
5% of patients underwent switch of access site 
due to difficulty to treat spasm [22], and Schussler 
et al. [23] found bleeding complications were 
Figure 3. Time to return of radial pulse. The horizontal 
line in the middle of each box indicates the median. The 
top and bottom borders of each box indicate the inter-
quartile range (IQR). The whiskers above and below the 
box indicate 5–95 percentiles, respectively; FMD — flow 
mediated dilation; NTG — nitroglycerin.
0
5
10
15
FMD
(n = 29)
NTG
(n = 28)
No-therapy
(n = 22)
20
T
im
e
 [
m
in
]
25
30
p = 0.859
p < 0.001
p < 0.001
Figure 2. The success rate of radial pulse recovery; FMD 
— flow mediated dilation; NTG — nitroglycerin.
Table 2. Secondary outcomes. 
Outcomes FMD (n = 30) NTG (n = 30) No-therapy (n = 30) P
Decreased blood pressure 1 (3%) 14 (47%) 1 (3%) < 0.001
Bradycardia 0 (0%) 1 (3%) 0 (0%) 1.000
Headache 0 (0%) 12 (40%) 0 (0%) < 0.001
Symptomatic hypotension 0 (0%) 1 (3%) 0 (0%) 1.000
FMD — flow mediated dilation; NTG — nitroglycerin
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increased with a switch to transfemoral approach. 
Unsuccessful puncture plays an important role in 
RAS, especially in patients with multiple failure 
of puncture or failure of delivering guidewire after 
puncture, which might result in pulse weakness or 
loss and difficulty of retrying puncture. Therefore, 
it is essential to develop an effective and accessible 
method for radial artery cannulation after RAS. FMD 
is endothelium-dependent vasodilation induced by 
elevated shear-stress caused by rapid blood flow and 
was developed as a noninvasive approach widely ap-
plied for the detection of endothelium function [13] 
and risk evaluation of coronary and peripheral artery 
disease [17, 18, 24]. FMD was applied for treating 
puncture-induced RAS, and the results indicated 
a high success rate (29/30, 97%), short time to 
return [7 (6.5–9) min] and few systemic complica-
tions. Similarly, Pancholy et al. [19] presented two 
successful cases using FMD for the removal of an 
entrapped radial sheath after PCI due to severe 
spasm after failure of NTG, verapamil, and sedative 
treatment. Moreover, a recent study by Collet et al. 
[25] showed that pressure-mediated dilatation (rapid 
injection with 10 mL of saline solution at a rate of 10 
mL per second with a pressure of 400 pounds per 
square inch [PSI] through the radial sheath) was 
superior to vasodilators (intra-arterial NTG 100 µg 
and verapamil 2.5 mg) for relieving RAS during the 
procedure, which showed the efficacy and safety of 
nonpharmacological methods based on shear stress-
induced vasodilation.
The administration of vasodilators before 
puncture could reduce the incidence of RAS. 
Sublingual NTG before puncture was reported to 
reduce times and duration of puncture [10], and 
subcutaneously infiltrated NTG was used to in-
crease the radial diameter, palpability and success 
rate of radial artery puncture [26]. Furthermore, 
a wait-and-watch strategy was applied for recovery 
from RAS in another study [11]. In the present 
study, three strategies (FMD, sublingual NTG and 
no-therapy) were compared, and FMD and sublin-
gual NTG methods demonstrated similar effects 
for recovery from RAS with a higher success rate 
in 30 min, and less recovery time compared with 
the wait-and-watch strategy. Similar results were 
shown in a study performed by Pancholy et al. [11]; 
in the group treated by a wait-and-watch strategy, 
the success of radial cannulation occurred in 8 out 
of 11 (72%) patients and the average time to re-
turn of the radial pulse was 18 ± 5 min. Operators 
needed to wait for 8 ± 1 min to regain the palpabil-
ity of the radial pulse in 18 out of 21 (90%) patients 
with sublingual NTG, with the risk of decreased 
blood pressure and headache. Furthermore, a lo-
cal subcutaneous injection of 1 mL NTG (200 µg/ 
/mL) facilitated successful recovery of the radial 
pulse in 21 out of 21 patients (100%) within 3 ± 
± 1 min without systemic adverse effects of NTG 
[11]. However, this strategy was not explored in 
the present study because local errhysis happened 
frequently after a failed radial artery puncture, and 
immediate compression was required to prevent 
local hematoma and then the local administration of 
NTG was delayed. Besides, bumps caused by sub-
cutaneous injection might influence the palpability 
of radial artery pulse and re-puncture. These might 
be reasons why this method is not widely applied. 
Limitations of the study
There are some limitations in this study. 
First, due to the wide use of transradial approach 
and improvement of medical instrumentation, the 
incidence of successful radial artery puncture is 
high and puncture-induced RAS is low (4.0% in 
our study). Also only 90 patients were included in 
this study. However, RAS is indeed an intractable 
phenomenon before CAG and PCI procedure, and 
the present aim was to develop a new noninvasive 
approach available for operators when RAS occurs. 
Second, without detection of blood flow and lu-
men diameter of radial artery by ultrasound, loss 
and recovery of radial artery pulse were assessed 
subjectively by operators. However, puncture of 
the radial artery is routinely based on palpation 
of the operators. Furthermore, the operator who 
assessed loss and recovery of pulse was experi-
enced and was the same one in every case, and 
the adjacent ulnar artery pulse was also touched 
as a reference, thus the pulse evaluation is reliable 
in this study.
Conclusions
Conclusions herein are similar to the admin-
istration of sublingual NTG, FMD improves radial 
cannulation by alleviating puncture-induced RAS 
with a higher success rate in 30 min and shorter 
time of recovery compared with the wait-and-
watch strategy. Moreover, systemic adverse effects 
caused by NTG, such as headache and decreased 
blood pressure were avoided and no local adverse 
reactions were observed. FMD is an effective, 
nonpharmacological and noninvasive method to 
relieve puncture-induced RAS and facilitates tran-
sradial cannulation after an initial failed attempt. 
Apart from this, the present study was designed 
as a pilot and open-labeled study because the three 
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treatments were entirely different and the opera-
tor who evaluated radial pulse immediately in the 
catheter lab was difficult to be blinded. Further 
study should be performed in an objective method 
under blind circumstances.
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